Linking molecular feature space and disease terms for the immunosuppressive drugrapamycin
Abstract
Next to development of novel
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Krankenhaus der Elisabethinen Linz, Internal Medicine III, Department of Nephrology, Fadingerstrasse 1, 4010 Linz, Austria
Fax: +43 732 7676 4306
Tel: +43 732 7676 4300
b Emergentec Biodevelopment GmbH, Gersthofer Straße 29-31, 1180 Vienna, Austria
c
Medical University of Vienna, Department of Internal Medicine III, Waehringer Guertel 18-20, 1090 Vienna, Austria
E-mail:
rainer.oberbauer@meduniwien.ac.at
Next to development of novel
A. Bernthaler, K. Mönks, I. Mühlberger, B. Mayer, P. Perco and R. Oberbauer, Mol. BioSyst., 2011, 7, 2863 DOI: 10.1039/C1MB05187C
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content